Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-25 @ 2:45 AM
NCT ID:
NCT03504033
Eligibility Criteria:
Inclusion Criteria:
* ≥ 3 segments liver resection
* ≥ 18 years
* Both gender
* American Society of Anesthesiologists (ASA) classification I-III
* Written informed consent prior to study participation
Exclusion Criteria:
Subjects, fulfilling one or more of the following exclusion criteria will not be included in the study:
* Severe pulmonary or airway disease
* Severe liver disease, accompanied by a Child-Pugh class \>A
* Allergy/hypersensitivity to study medications
* ASA ≥ IV
* Patients susceptible to malignant hyperthermia
* Women who are pregnant, breast-feeding or women of childbearing potential not using adequate contraceptive methods
* Patients with preeclampsia or eclampsia
* Patients legally unable to give written informed consent.
* Patients with risk of high oxygen demand
* Patient with seriously impaired cardiac function
* All contraindications for xenon anesthesia according to the summary of product characteristics LENOXe
* Patient participates in a parallel interventional clinical trial during this study or receives an investigational drug within 30 days prior to inclusion into this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03504033
Study Brief:
Protocol Section:
NCT03504033